Dyne Therapeutics joined Parent Project Muscular Dystrophy (PPMD) for a webinar on March 31, 2021 to provide an overview of the company’s mission, its novel FORCE platform designed to revolutionize drug delivery to muscle, and the company’s Duchenne drug development program.

If you missed the live event, the recording can be found below.

 

Watch the Recording